EP2968174
Töflur með lyfjasamsetningu úr súlfatsöltum til tvenns konar nota og aðferðir við notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2014EP published:
16.10.2019EP application number:
14722461.2
EP translation filed:
12.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2021
Title:
DUAL USE ORAL PHARMACEUTICAL COMPOSITION TABLETS OF SULFATE SALTES AND METHODS OF USE THEREOF
Timeline
Today
14.3.2014EP application
16.10.2019EP Publication
12.12.2019Translation submitted
15.1.2020Registration published
13.3.2021Expires
Owner
Name:
Braintree Laboratories, Inc.Address:
60 Columbian Street West, 02184, Braintree, MA, US
Inventor
Name:
DENNETT, Edmund V. Jr.Address:
Walpole, MA, US
Name:
WELLS, David S.Address:
Shrewsbury, MA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201361798759 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 33/04, A61P 1/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.2.2020
Expires: 13.3.2021
Payer: Árnason Faktor ehf.